Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultrasonix was a medical device company specializing in the development of high-end diagnostic ultrasound imaging systems. The company's "Sonix" platform featured an open architecture, making it a preferred choice for both clinical use and medical research. Their systems were primarily utilized in point-of-care applications such as anesthesia, emergency medicine, and musculoskeletal imaging. In 2013, Ultrasonix was acquired by Analogic Corporation for approximately $37 million, and its technology was subsequently integrated into the BK Medical brand, which is now part of GE Healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ultrasonix.